The Lancet Haematology

Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial

Pub Date : 2024-06-01 DOI: 10.1016/s2352-3026(24)00133-9 J. Gunther, Jie Xu, M. Bhutani, P. Strati, Penny Q Fang, Susan Y. Wu, B. Dabaja, Wenli Dong, Priya R Bhosale, Christopher Flowers, R. Nair, Luis E Malpica Castillo, L. Fayad, S. Iyer, Simrit Parmer, Michael Wang, Hun Ju Lee, F. Samaniego, J. Westin, Sairah Ahmed, Chijioke Nze, P. Jain, S. Neelapu, M. Rodriguez, Dai Chihara, L. Nastoupil, C. Pinnix

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

Pub Date : 2024-06-01 DOI: 10.1016/s2352-3026(24)00139-x Yu Hu, Xiaofan Liu, Huixing Zhou, Shujie Wang, Ruibin Huang, Yi Wang, Xin Du, Jing Sun, Zeping Zhou, Zhenyu Yan, Wenming Chen, Wei Wang, Qingchi Liu, Qingshu Zeng, Yuping Gong, Jie Yin, Xuliang Shen, Baodong Ye, Yun Chen, Yajing Xu, Huiping Sun, Yunfeng Cheng, Zhuogang Liu, Chunling Wang, Guolin Yuan, Xiaohui Zhang, Xin Li, Peng Cheng, Xinhong Guo, Zhongxing Jiang, Feng'e Yang, Linhua Yang, C. Luo, Taiwu Xiao, Sisi Fu, Hongyan Yin, Xiaojun Guo, Qian Xu, Songhua Fan, Michael M Shi, Weiguo Su, Heng Mei, Renchi Yang

Sovleplenib in immune thrombocytopenia

Pub Date : 2024-06-01 DOI: 10.1016/s2352-3026(24)00180-7 María Eva Mingot-Castellano